2019
DOI: 10.3389/fped.2018.00430
|View full text |Cite
|
Sign up to set email alerts
|

Growth Concerns in Coffin–Lowry Syndrome: A Case Report and Literature Review

Abstract: Mutation of RPS6KA3 can induce Coffin–Lowry syndrome, an X-linked syndrome. The case here reported manifests its signature characteristic of short stature, facial dysmorphism, development retardation, hearing defect. The mutation of RPS6KA3 we detected by NGS analysis is c.2185 C > T. The short stature is a noteworthy problem we discuss here to improve the patient's growth and development. The efficacy and safety of application of growth hormone analogs on patients with CLS are not confirmed and need to be car… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…Phosphorylation of substrates by RSK2 is important during development; thus, germline loss-of-function variants in RPS6KA3 , the gene encoding RSK2, cause Coffin-Lowry syndrome, a disorder characterized by growth and developmental delay as well as other skeletal anomalies ( 35 , 36 , 37 , 38 ). The recent identification of SPRED2 loss-of-function variants in individuals with Noonan syndrome, which also has phenotypic skeletal features, suggests a genetic link between SPRED2 and RSK2 with implications for proper skeletal development ( 11 , 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…Phosphorylation of substrates by RSK2 is important during development; thus, germline loss-of-function variants in RPS6KA3 , the gene encoding RSK2, cause Coffin-Lowry syndrome, a disorder characterized by growth and developmental delay as well as other skeletal anomalies ( 35 , 36 , 37 , 38 ). The recent identification of SPRED2 loss-of-function variants in individuals with Noonan syndrome, which also has phenotypic skeletal features, suggests a genetic link between SPRED2 and RSK2 with implications for proper skeletal development ( 11 , 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…With advancing molecular technology, molecular genetic techniques are being used for the diagnosis of genetic diseases, facilitating the early diagnosis and monitoring of patients. From the perspective of CLS cases, diagnosis in recent years has mostly relied on high-throughput sequencing technology [ 13 , 14 , 15 ]. In this study, a high-throughput sequencing platform was used for sequencing.…”
Section: Discussionmentioning
confidence: 99%
“…A total of 13–20% of male CLS and 3–7% of female CLS presented with stimulus-induced drop episodes (SIDEs) ( Rojnueangnit et al, 2014 ). In addition, a few CLS patients presented with diabetes type 2 ( Boulos et al, 2021 ), epileptic seizures ( Gschwind et al, 2015 ), growth retardation ( Lv et al, 2019 ), and hearing or vision problems ( Hunter, 2002 ). The risk of childhood-onset schizophrenia (COS) might be increased in CLS patients ( Ambalavanan et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%